Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2012
09/11/2012US8263614 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
09/11/2012US8263597 Indazole compounds as CCR1 receptor antagonists
09/11/2012US8263349 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
09/11/2012US8263121 Solid pharmaceutical preparation
09/11/2012US8263070 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders
09/11/2012US8262054 Furnace mount
09/11/2012CA2751002C Method for treatment of diseases
09/11/2012CA2532450C Chlorthalidone combinations
09/11/2012CA2529367C Preventing atrial fibrillation (af) with the use of statin drugs
09/11/2012CA2508573C Novel coumarins, their carboxamide derivatives, preparation methods, compositions, and uses
09/11/2012CA2451577C Gene delivery vectors with cell type specificity for mesenchymal stem cells
09/11/2012CA2326407C Retroviral vectors including modified envelope escort proteins
09/07/2012WO2012119103A2 Compositions and methods for mobilization of stem cells
09/07/2012WO2012119078A2 COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE
09/07/2012WO2012118308A2 Composition for preventing and treating cardiovascular diseases, containing pyrazole derivative
09/07/2012WO2012118193A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118154A1 Novel vitamin d receptor modulator with partial agonist activity
09/07/2012WO2012118097A1 Cell sheet having hyaluronic acid production ability and method for producing same
09/07/2012WO2012117219A1 Pyrrolidine derivatives as selective glycosidase inhibitors and uses thereof
09/07/2012WO2012117136A1 Lactoferrin hydrolysate fraction with a low molecular weight for treating hypertension
09/07/2012WO2012117062A1 Piperidinyl benzoimidazole derivatives as mpges-1 inihibitors
09/07/2012WO2012116997A1 TREATMENT OF ARTERIAL AGEING BY HMG CoA REDUCTASE INHIBITOR
09/07/2012WO2012116996A1 Treatment of arterial ageing by raas inhibitor
09/07/2012WO2012116985A1 TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
09/07/2012WO2012080982A3 Functional food preparation and use thereof
09/07/2012WO2011089234A8 Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
09/07/2012CA2829051A1 Compositions and methods comprising c16:1n7-palmitoleate
09/06/2012US20120226347 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
09/06/2012US20120225945 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
09/06/2012US20120225941 COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE
09/06/2012US20120225937 Crystalline forms and processes for the preparation of pg12 receptor agonists
09/06/2012US20120225915 Compositions and Methods of Using R(+) Pramipexole
09/06/2012US20120225908 Hydroxyl compounds and compositions for cholesterol management and related uses
09/06/2012US20120225906 Piperidine renin inhibitors
09/06/2012US20120225904 New 7-Phenyl-[1,2,4]triazolo[4,3-a]Pyridin-3(2H)-One Derivatives
09/06/2012US20120225896 Novel 2-pyridone derivative and pharmaceutical product containing same
09/06/2012US20120225892 [1,5]-Diazocin Derivatives
09/06/2012US20120225889 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
09/06/2012US20120225887 Glucokinase Activators
09/06/2012US20120225885 Imidazole derivatives and methods of use thereof
09/06/2012US20120225883 Compounds for inflammation and immune-related uses
09/06/2012US20120225882 Selective hydroxamate based mmp inhibitors
09/06/2012US20120225879 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases
09/06/2012US20120225878 Compounds
09/06/2012US20120225876 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/06/2012US20120225875 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/06/2012US20120225874 Bicyclic derivatives as cetp inhibitors
09/06/2012US20120225866 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
09/06/2012US20120225865 Arylcyclohexylethers of dihydrotetraazabenzoazulenes
09/06/2012US20120225861 6-O-Substituted Benzoxazole and Benzothiazole Compounds and Methods of Inhibiting CSF-1R Signaling
09/06/2012US20120225855 Triazolopyridine jak inhibitor compounds and methods
09/06/2012US20120225847 Squaric acid derivatives as inhibitors of the nicotinamide
09/06/2012US20120225812 Substituted fused pyrimidine compounds, its preparation and uses thereof
09/06/2012US20120225808 Pharmaceutical Composition for Preventing / Treating TRPV1 Activity-Related and Inflammation-Related Diseases or Conditions Containing Maillard Peptide Separated from Well-Aged Traditional Soy Sauce as Active Ingredient
09/06/2012US20120225133 Use of an agent that restores tissue perfusion and oxygenation
09/06/2012US20120225118 Compositions for delivery of insoluble agents
09/06/2012US20120225114 Modifying Macrophage Phenotype for Treatment of Disease
09/06/2012US20120225097 Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
09/06/2012US20120225069 Use of a compound for reducing the biological effectiveness of il-6
09/06/2012US20120225063 Treatment response to anti-angiogenic therapies
09/06/2012US20120225057 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
09/06/2012US20120225056 Methods and compositions for treating complement-associated disorders
09/06/2012US20120225040 Methods and compositions for treating tissue using silk proteins
09/06/2012US20120225032 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/06/2012US20120225028 Compositions and methods for mobilization of stem cells
09/06/2012US20120225012 Composition for hard tissue repair
09/05/2012EP2495255A1 Glycosylated form of antigenic glp-1 analogue
09/05/2012EP2495250A2 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
09/05/2012EP2495244A1 Piperidinyl benzoimidazole derivatives as mPGEs-1 inhibitors
09/05/2012EP2495242A2 Novel vascular leak inhibitor
09/05/2012EP2495236A1 Benzazepine compound
09/05/2012EP2494990A1 Agent for regeneration and/or protection of nerves
09/05/2012EP2494988A1 Antagonist antibodies against EPHB3
09/05/2012EP2494979A1 Use of ginkgo biloba leaf extract to prevent and treat complications following arteriosclerosis surgery and reappearance of arteriosclerosis
09/05/2012EP2494964A1 Combinations of valsartan and amlodipine
09/05/2012EP2494963A1 Combinations of valsartan and amlodipine
09/05/2012EP2494865A2 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using same
09/05/2012EP2493910A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
09/05/2012EP2493866A1 Tricyclic heterocyclic compounds
09/05/2012EP2493845A1 Substituted 3-phenylpropionic acids and the use thereof
09/05/2012EP2493496A1 Use of gstp1
09/05/2012EP2493495A2 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia
09/05/2012EP2493478A1 Concentrated therapeutic phospholipid compositions
09/05/2012EP2493474A2 Methods and compositions for sustained delivery of drugs
09/05/2012EP2493296A1 Alleviating oxidative stress disorders with pufa derivatives
09/05/2012CN202409448U Anorectum fumigator
09/05/2012CN202408105U Healthcare pillow
09/05/2012CN1984996B Replication competent viruses capable of silencing virus inhibitory factor expression
09/05/2012CN1970746B Bifunctional variants of recombinant tissue-type plasminogen activator with platelet aggregation inhibitory activity
09/05/2012CN1955170B Class I tanshinone II A derivative and its application in pharmacy
09/05/2012CN1636572B Compositions and methods for treatment of mitochondrial diseases
09/05/2012CN102656175A Crystalline forms of prasugrel salts
09/05/2012CN102656171A Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems
09/05/2012CN102656166A Crystalline salts of methyl 2-((r)-(3-chloro phenyl) ((r)-l-((s)-2-(methylamino)-3-((r)-tetrahydro-2h-pyran-3-yl)propylcarbamoyl)
09/05/2012CN102656153A Novel vascular leak inhibitor
09/05/2012CN102656149A Benzamide compound
09/05/2012CN102656141A Hematopoietic growth factor mimetic small molecule compounds and their uses
09/05/2012CN102654488A Method for detecting dripping pills of Chinese medicine composite with function of removing heat to cool blood and promoting blood circulation to stop pains
09/05/2012CN102653539A Compound for resisting platelet aggregation and medicament combination thereof
09/05/2012CN102653515A Polycationic compounds and uses thereof
1 ... 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 ... 1595